These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7833174

  • 1. Intracranial iotrolan distribution following cervical myelography. Postmyelographic registration of adverse effects, psychometric assessment and electroencephalographic recording.
    Fiirgaard B, Madsen HH, Svare U, Eriksen FB, Skjødt T, Zeeberg I.
    Acta Radiol; 1995 Jan; 36(1):77-81. PubMed ID: 7833174
    [Abstract] [Full Text] [Related]

  • 2. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.
    Shaw DD, Bach-Gansmo T, Dahlstrom K.
    Invest Radiol; 1985 Jan; 20(1 Suppl):S44-50. PubMed ID: 3882616
    [Abstract] [Full Text] [Related]

  • 3. Iohexol: a new nonionic contrast medium for myelography and cisternography with markedly reduced neurotoxicity.
    Gonsette RE, Liesenborghs L.
    Invest Radiol; 1985 Jan; 20(1 Suppl):S32-6. PubMed ID: 3871751
    [Abstract] [Full Text] [Related]

  • 4. Tolerance of iotrolan 190 and cerebrospinal fluid-diluted iotrolan 300 at the same iodine concentration in lumbar myelography.
    Wenzel-Hora BI, Potthoff PC, Jänicke UA.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Jan; 128():148-52. PubMed ID: 2568783
    [Abstract] [Full Text] [Related]

  • 5. Intracranial iohexol-distribution following cervical myelography, postmyelographic registration of adverse effects, psychometric assessment and electroencephalographic recording.
    Olsen NK, Madsen HH, Eriksen FB, Svare U, Zeeberg I.
    Acta Neurol Scand; 1990 Nov; 82(5):321-8. PubMed ID: 2281749
    [Abstract] [Full Text] [Related]

  • 6. Neural tolerance of iotrolan 300 in ascending cervical myelography: results of a multicenter study.
    Behrends B, Albrecht A, Bingas B, Becker H, Brunke J, von Einsiedel H, Mariss G, Schmidt K, Thun F, Valavanis A.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Nov; 128():171-5. PubMed ID: 2568789
    [Abstract] [Full Text] [Related]

  • 7. A prospective comparison of iotrolan, iohexol and iopamidol for lumbar myelography.
    Lamb J, McAllister V, Nelson M, Bartlett R, Smith I, Deopugari CE.
    Acta Radiol Suppl; 1986 Nov; 369():524-7. PubMed ID: 2980547
    [Abstract] [Full Text] [Related]

  • 8. [Intracranial distribution of iohexol and iotrolan after cervical myelography].
    Fiirgaard B, Madsen HH, Svare U, Skjødt T, Zeeberg I.
    Ugeskr Laeger; 1995 Jul 03; 157(27):3901-4. PubMed ID: 7645065
    [Abstract] [Full Text] [Related]

  • 9. [Adverse reactions and intracranial contrast medium after myelography].
    Fujii K, Hashimoto T, Isaza M, Hashimoto T, Hirabuki N, Miura T, Mitomo M, Kozuka T, Kawai R.
    Rinsho Hoshasen; 1989 Mar 03; 34(3):323-7. PubMed ID: 2739082
    [Abstract] [Full Text] [Related]

  • 10. A prospective comparison of iotrolan and iohexol in lumbar myelography.
    Wagner A, Jensen C, Saebye A, Rasmussen TB.
    Acta Radiol; 1994 Mar 03; 35(2):182-5. PubMed ID: 8172748
    [Abstract] [Full Text] [Related]

  • 11. Comparison of nonionic contrast agents iohexol and iotrolan for cisternal myelography in dogs.
    van Bree H, Van Rijssen B, Van Ham L.
    Am J Vet Res; 1991 Jun 03; 52(6):926-33. PubMed ID: 1883098
    [Abstract] [Full Text] [Related]

  • 12. [Clinical experience of iotrolan].
    Ishikawa M, Handa H.
    Nihon Geka Hokan; 1986 May 01; 55(3):485-9. PubMed ID: 3800545
    [No Abstract] [Full Text] [Related]

  • 13. Iotrolan versus iopamidol for cervical myelography: a randomized double-blind trial.
    Coutinho C, McGeorge A, Macpherson P, Teasdale E.
    Br J Radiol; 1988 Oct 01; 61(730):965-7. PubMed ID: 3056560
    [No Abstract] [Full Text] [Related]

  • 14. [Iotrolan versus iopamidol. A controlled double-blind study with lumbar myelography].
    Maier B, Gerber U, König M, Stetter G.
    Radiologe; 1992 Aug 01; 32(8):393-6. PubMed ID: 1410326
    [Abstract] [Full Text] [Related]

  • 15. Iohexol for cervical myelography via C1-C2 puncture: study of efficacy and adverse reactions.
    Latchaw RE, Sackett JF, Turski PA, Shaw DD.
    AJNR Am J Neuroradiol; 1985 Aug 01; 6(6):927-30. PubMed ID: 3934931
    [Abstract] [Full Text] [Related]

  • 16. [Hysterosalpingography using iotrolan--a new contrast medium].
    Jensen HJ, Dons-Jensen H, Kamal KM.
    Aktuelle Radiol; 1993 Sep 01; 3(5):292-4. PubMed ID: 8399416
    [Abstract] [Full Text] [Related]

  • 17. [Direct cervical myelography using iotrolan 300].
    Volle E, Hedde JP, Gormanns R.
    Rofo; 1991 Feb 01; 154(2):197-201. PubMed ID: 1847546
    [Abstract] [Full Text] [Related]

  • 18. Iotrolan. The first dimeric non-ionic contrast medium for the subarachnoid space.
    Wenzel-Hora BI.
    Acta Radiol Suppl; 1986 Feb 01; 369():545-8. PubMed ID: 2980554
    [Abstract] [Full Text] [Related]

  • 19. Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects.
    Ndosi BN, Ndosi NK, Kazema RR.
    Cent Afr J Med; 1996 Jul 01; 42(7):192-5. PubMed ID: 8936782
    [Abstract] [Full Text] [Related]

  • 20. Comparison in myelography between iodixanol 270 and 320 mgI/ml and iotrolan 300 mgI/ml: a multicentre, randomised, parallel-group, double-blind, phase III trial.
    Palmers Y, Kuhn FP, Petersen D, De Greef D.
    Eur Radiol; 2002 Mar 01; 12(3):686-91. PubMed ID: 11870488
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.